Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 18.99 M18.52 M17.53 M17.21 M 72.24 M Research & development ———— — Operating income -34.13 M-8.38 M-10.47 M-5.69 M -58.67 M Non-Operating Income, Total -11 K-131 K-73 K1.53 M 1.31 M Interest expense, net of interest capitalized ——400 K— — Non-Operating Income, excl. Interest Expenses -198 K-326 K-221 K1.26 M 511 K Unusual income/expense 187 K195 K148 K273 K 803 K Pretax income -34.14 M-8.51 M-10.54 M-4.16 M -57.36 M Equity in earnings ———— — Taxes 9 0009 00011 K-102 K -73 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -34.15 M-8.52 M-10.55 M-4.06 M -57.29 M Discontinued operations ———— — Net income -34.15 M-8.52 M-10.55 M-4.06 M -57.29 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -34.15 M-8.52 M-10.55 M-4.06 M -57.29 M Basic earnings per share (Basic EPS) -1.65-0.41-0.5-0.18 -2.74 Diluted earnings per share (Diluted EPS) -1.65-0.41-0.5-0.18 -2.74 Average basic shares outstanding 20.76 M20.89 M21.01 M20.92 M — Diluted shares outstanding 20.76 M20.89 M21.01 M20.92 M — EBITDA -31.85 M-6.1 M21.01 M25.61 M 8.67 M EBIT -34.13 M-8.38 M18.61 M23.18 M -720 K Cost of revenue 36.78 M31.95 M2.13 M0 70.85 M Other cost of goods sold ——2.13 M0 — Depreciation & amortization (cash flow) 2.28 M2.28 M2.4 M2.43 M 9.39 M